Complera Dosage
Generic name: emtricitabine, rilpivirine, and tenofovir
Brand names: Complera, Odefsey
Drug class: Antiviral combinations
Medically reviewed by A Ras MD.
Recommended Adult Dosing
Dosage forms: TAB: 200 mg/25 mg/300 mg
HIV infection
- [tx-naive]
- Dose: 1 tab PO qd; Info: for pts w/ HIV-1 RNA <100,000 and CD4 >200; give w/ food
- [tx-experienced]
- Dose: 1 tab PO qd; Info: for pts w/ HIV-1 RNA <50; give w/ food
- [pregnant pts]
- Dose: 1 tab PO qd; Info: for pts w/ HIV-1 RNA <50 on stable rilpivirine-containing regimen prior to pregnancy; give w/ food
HIV post-exposure prophylaxis, nonoccupational
- [1 tab PO qd]
- Info: refer to HIV Post-Exposure Prophylaxis, Nonoccupational table; give w/ food
Renal dosing
- CrCl <50: avoid use; dose adjustment not possible w/ fixed-dose combo
- HD/PD: avoid use; dose adjustment not possible w/ fixed-dose combo
Hepatic dosing
- [see below]
- Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined
Recommended Peds Dosing
- Dosage forms: TAB: 200 mg/25 mg/300 mg
HIV infection
- [>35 kg, tx-naive]
- Dose: 1 tab PO qd; Info: for pts w/ HIV-1 RNA <100,000; give w/ food
- [>35 kg, tx-experienced]
- Dose: 1 tab PO qd; Info: for pts w/ HIV-1 RNA <50; give w/ food
- [pregnant pts]
- Dose: 1 tab PO qd; Info: for pts w/ HIV-1 RNA <50 on stable rilpivirine-containing regimen prior to pregnancy; give w/ food
Renal dosing
- CrCl <50: avoid use; dose adjustment not possible w/ fixed-dose combo
- HD/PD: avoid use; dose adjustment not possible w/ fixed-dose combo
Hepatic dosing
- Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined
SRC: NLM .